Inventor
NADUTHAMBI DEVAN
US36 patents
⚠️ This page may combine multiple inventors who share the name “NADUTHAMBI DEVAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
35 patentsUS10703733B2Jul 7, 2020
MCL-1 inhibitors
GILEAD SCIENCES INC12 citations93
US11897892B2Feb 13, 2024
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC6 citations85
US10988451B2Apr 27, 2021
MCL-1 inhibitors
GILEAD SCIENCES INC10 citations85
US11613546B2Mar 28, 2023
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC9 citations84
US9765060B2Sep 19, 2017
Phosphatidylinositol 3-kinase inhibitors
GILEAD SCIENCES INC13 citations83
US10774071B2Sep 15, 2020
PD-1/PD-L1 inhibitors
GILEAD SCIENCES INC7 citations82
US10710986B2Jul 14, 2020
PD-1/PD-L1 inhibitors
GILEAD SCIENCES INC4 citations82
US12187734B2Jan 7, 2025
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC1 citations74
US11643400B2May 9, 2023
MCL-1 inhibitors
GILEAD SCIENCES INC4 citations74
US11773122B2Oct 3, 2023
Phospholipid compounds and uses thereof
GILEAD SCIENCES INC4 citations73
US11667652B2Jun 6, 2023
MCL1 inhibitors
GILEAD SCIENCES INC2 citations72
US10221197B2Mar 5, 2019
Phosphatidylinositol 3-kinase inhibitors
GILEAD SCIENCES INC2 citations72
US10092563B2Oct 9, 2018
Phosphatidylinositol 3-kinase inhibitors
GILEAD SCIENCES INC2 citations71
US10040781B2Aug 7, 2018
Tank-binding kinase inhibitor compounds
GILEAD SCIENCES INC3 citations71
US12091420B2Sep 17, 2024
SARS-COV2 main protease inhibitors
GILEAD SCIENCES INC3 citations70
US10072001B2Sep 11, 2018
Tank-binding kinase inhibitor compounds
GILEAD SCIENCES INC3 citations70
US12202842B2Jan 21, 2025
MCL1 inhibitors
GILEAD SCIENCES INC0 citations62
US12162844B2Dec 10, 2024
MCL-1 inhibitors
GILEAD SCIENCES INC0 citations62
US11718637B2Aug 8, 2023
Prodrugs of 4′-C-substituted-2-halo-2′- deoxyadenosine nucleosides and methods of making and using the same
GILEAD SCIENCES INC0 citations62
US12473314B2Nov 18, 2025
Phospholipid compounds and uses thereof
GILEAD SCIENCES INC0 citations61
US12338233B2Jun 24, 2025
PD-1/Pd-L1 inhibitors
GILEAD SCIENCES INC0 citations61
US12269812B2Apr 8, 2025
PD-1/PD-L1 inhibitors
GILEAD SCIENCES INC0 citations61
US12030904B2Jul 9, 2024
Phospholipid compounds and uses thereof
GILEAD SCIENCES INC0 citations61
US11555029B2Jan 17, 2023
PD-1/PD-L1 inhibitors
GILEAD SCIENCES INC1 citations61
US12410183B2Sep 9, 2025
Sars-cov2 main protease inhibitors
GILEAD SCIENCES INC1 citations60
US12116380B2Oct 15, 2024
Phospholipid compounds and methods of making and using the same
GILEAD SCIENCES INC0 citations58
US12110305B2Oct 8, 2024
Prodrugs of phosphonamide nucleotide analogues and their pharmaceutical use
GILEAD SCIENCES INC0 citations51
US10253019B2Apr 9, 2019
Tank-binding kinase inhibitor compounds
GILEAD SCIENCES INC0 citations51
US12590062B2Mar 31, 2026
PD-1/PD-L1 inhibitors
GILEAD SCIENCES INC0 citations50
US11021467B2Jun 1, 2021
Phosphatidylinositol 3-kinase inhibitors
GILEAD SCIENCES INC0 citations50
US10899735B2Jan 26, 2021
PD-1/PD-L1 inhibitors
GILEAD SCIENCES INC0 citations50
US10259811B2Apr 16, 2019
Tank-binding kinase inhibitor compounds
GILEAD SCIENCES INC0 citations49
US10479770B2Nov 19, 2019
Phosphatidylinositol 3-kinase inhibitors
GILEAD SCIENCES INC0 citations39
US10316049B2Jun 11, 2019
Tank-binding kinase inhibitor compounds
GILEAD SCIENCES INC0 citations39
US10214519B2Feb 26, 2019
Phosphatidylinositol 3-kinase inhibitors
GILEAD SCIENCES INC0 citations39